| Anesthesiologist Group 1 N = 939 | Resident Group 2 N = 2644 | CRNA/CAA Group 3 N = 11,501 | p-value |
---|---|---|---|---|
MAP < 55mmHg, >15 min, (%, n) | 2.8%, (26) | 2.5%, (66) | 2.7%, (310) | 0.11 |
MAP < 55mmHg, > 1 min, (%, n) | 29.7% (279) | 30.4% (804) | 28.6% (3289) | 0.10 |
minutes > 1, MAP < 55mmHg | 5 [3 - 9] | 5 [2 - 9] | 4 [2 - 8] | 0.26 |
MAP < 65mmHg, >15 min, (%, n) | 31.2%, (293) | 31.9%, (843) | 30.3%, (3485) | 0.62 |
minutes >15, MAP < 65mmHg, | 29 [21–44] | 30 [22–45] | 31 [21–44] | 0.48 |
Cardiac Complication, (%, n) | 0.2%, (2) | 0.5%, (13) | 0.5%, (56) | 0.25 |
Myocardial Infarction, (%, n) | 0.1%, (1) | 0.2%, (5) | 0.3%, (34) | 0.56 |
Pulmonary Complications, | Â | Â | Â | Â |
Respiratory Failure, (%, n) | 0.4% (4) | 0.6% (17) | 0.6% (75) | 0.64 |
Pneumonia (%, n) | 0.0% (0) | 0.1% (4) | 0.2% (23) | 0.44 |
Pulmonary Embolus (%, n) | 0.0% (0) | 0.07% (2) | 0.05% (6) | 0.79 |
MPOG AKI Stage (n) | 225 | 1231 | 5159 | 0.08 |
0, (%, n) | 91.1% (205) | 93.2% (1147) | 91.8% (4735) | Â |
1, (%, n) | 6.2% (14) | 5.7% (70) | 6.3% (324) | Â |
2, (%, n) | 2.7% (6) | 1.0% (72) | 1.2% (64) | Â |
3, (%, n) | 0.0% (0) | 0.2% (2) | 0.7% (36) | Â |
Length of Stay, days | 0.0 [0.0–1.0] †| 1.0 [0.0–3.0] | 0.0 [0.0–2.0] | < 0.001 |
30 Day Mortality, (%, n) | 0.2% (2) | 0.3% (8) | 0.4% (46) | 0.29 |